Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

AstraZeneca, MSD raise prostate cancer awareness with ‘Never Miss’ campaign

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

Huge inequalities found in access to myeloma clinical trials in Europe, says MPE

6th Annual 3D Cell Culture Conference

SMC gives Bayer’s CKD therapy Kerendia the green light in Scotland

agitation

definition of Schizophrenia

Market Access/ News/ News

BioXcel gets first approval for agitation drug Igalmi

Phil Taylor agitation, BioXcel, bipolar disorder, Igalmi, Psychiatry, regulatory approval, schizophrenia 0 Comment

BioXcel Therapeutics has claimed its first product approval, getting a green light from the FDA for Igalmi as

X

BioXcel gets first approval for agitation drug Igalmi

https://pharmaphorum.com/news/bioxcel-gets-first-approval-for-agitation-drug-igalmi/

Inner Workings

Market Access/ News/ News

BioXcel’s agitation drug gets FDA Fast Track

George Underwood agitation, Alzheimer's, BioXcel, schizophrenia 0 Comment

The FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting

X

BioXcel’s agitation drug gets FDA Fast Track

https://pharmaphorum.com/news/bioxcels-agitation-drug-gets-fda-fast-track/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

AstraZeneca leads winners at Reuters Pharma Awards 2022
Two drug-related deaths reported on eve of Phase 3 lecanemab data
Another Twitter blow to science as Musk ends COVID misinformation policy
Genentech withdraws US indication of Tecentriq for bladder, urinary tract cancer
Veeva Systems Summit, Madrid - pharmaphorum reflects

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com